{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:21:45Z","timestamp":1786980105928,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03571-3","type":"journal-article","created":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T08:15:40Z","timestamp":1734164140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and safety of cysteamine 5% cream for the management of melasma: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"317","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6683-5903","authenticated-orcid":false,"given":"Ferra Olivia","family":"Mawu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus Mario","family":"Christopher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,14]]},"reference":[{"issue":"3","key":"3571_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s13555-017-0194-1","volume":"7","author":"OA Ogbechie-Godec","year":"2017","unstructured":"Ogbechie-Godec OA, Elbuluk N (2017) Melasma: an up-to-date comprehensive review. Dermatol Ther (Heidelb) 7(3):305\u2013318. https:\/\/doi.org\/10.1007\/s13555-017-0194-1","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"5","key":"3571_CR2","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1590\/abd1806-4841.20143063","volume":"89","author":"AC Handel","year":"2014","unstructured":"Handel AC, Miot LD, Miot HA (2014) Melasma: a clinical and epidemiological review. Bras Dermatol 89(5):771\u2013782. https:\/\/doi.org\/10.1590\/abd1806-4841.20143063","journal-title":"Bras Dermatol"},{"issue":"12","key":"3571_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.33192\/Smj.2021.109","volume":"73","author":"MA Abdalla","year":"2021","unstructured":"Abdalla MA (2021) Melasma clinical features, diagnosis, epidemiology and etiology: an update review. Siriraj Med J 73(12):841\u2013850. https:\/\/doi.org\/10.33192\/Smj.2021.109","journal-title":"Siriraj Med J"},{"issue":"4","key":"3571_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0019-5154.57602","volume":"54","author":"D Bandyopadhyay","year":"2009","unstructured":"Bandyopadhyay D (2009) Topical treatment of melasma. Indian J Dermatol 54(4):303\u2013309. https:\/\/doi.org\/10.4103\/0019-5154.57602","journal-title":"Indian J Dermatol"},{"issue":"1","key":"3571_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1365-4632.2007.03351.x","volume":"47","author":"R Charl\u00edn","year":"2008","unstructured":"Charl\u00edn R, Barcaui CB, Kac BK, Soares DB, Rabello-Fonseca R, Azulay-Abulafia L (2008) Hydroquinone-induced exogenous ochronosis: a report of four cases and usefulness of dermoscopy. Int J Dermatol 47(1):19\u201323. https:\/\/doi.org\/10.1111\/j.1365-4632.2007.03351.x","journal-title":"Int J Dermatol"},{"issue":"5","key":"3571_CR6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.4103\/ijdvl.IJDVL_209_17","volume":"85","author":"A Das","year":"2019","unstructured":"Das A, Ghosh A, Kumar P (2019) Chemical leukoderma due to hydroquinone: an unusual phenomenon. Indian J Dermatol Venereol Leprol 85(5):567. https:\/\/doi.org\/10.4103\/ijdvl.IJDVL_209_17","journal-title":"Indian J Dermatol Venereol Leprol\u00a0"},{"issue":"15\u201316","key":"3571_CR7","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.drudis.2013.02.003","volume":"18","author":"M Besouw","year":"2013","unstructured":"Besouw M, Masereeuw R, van den Heuvel L, Levtchenko E (2013) Cysteamine: an old drug with new potential. Drug Discov Today 18(15\u201316):785\u2013792. https:\/\/doi.org\/10.1016\/j.drudis.2013.02.003","journal-title":"Drug Discov Today"},{"issue":"11","key":"3571_CR8","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1111\/jocd.14494","volume":"20","author":"N Ahramiyanpour","year":"2021","unstructured":"Ahramiyanpour N, Saki N, Akbari Z, Shamsi-Meymandi S, Amiri R, Heiran A (2021) Efficacy of topical cysteamine hydrochloride in treating melasma: a systematic review. J Cosmet Dermatol 20(11):3593\u20133602. https:\/\/doi.org\/10.1111\/jocd.14494","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"3571_CR9","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1111\/ajd.13432","volume":"62","author":"J Nguyen","year":"2021","unstructured":"Nguyen J, Remyn L, Chung IY, Honigman A, Gourani-Tehrani S, Wutami I et al (2021) Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: a randomised, double-blinded trial. Australas J Dermatol 62(1):e41\u2013e46. https:\/\/doi.org\/10.1111\/ajd.13432","journal-title":"Australas J Dermatol"},{"issue":"12","key":"3571_CR10","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1111\/ijd.15146","volume":"59","author":"PB Lima","year":"2020","unstructured":"Lima PB, Dias JAF, Cassiano D, Esposito ACC, Bagatin E, Miot LDB et al (2020) A comparative study of topical 5% cysteamine versus 4% hydroquinone in the treatment of facial melasma in women. Int J Dermatol 59(12):1531\u20131536. https:\/\/doi.org\/10.1111\/ijd.15146","journal-title":"Int J Dermatol"},{"key":"3571_CR11","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"3571_CR12","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"issue":"7414","key":"3571_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"issue":"6","key":"3571_CR14","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, Wan X, Liu J, Tong T (2018) Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res 27(6):1785\u20131805. https:\/\/doi.org\/10.1177\/0962280216669183","journal-title":"Stat Methods Med Res"},{"key":"3571_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol 14:135. https:\/\/doi.org\/10.1186\/1471-2288-14-135","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"3571_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1080\/09546634.2017.1351608","volume":"29","author":"S Farshi","year":"2018","unstructured":"Farshi S, Mansouri P, Kasraee B (2018) Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a new measurement method: a randomized double blind placebo controlled study. J Dermatolog Treat 29(2):182\u2013189. https:\/\/doi.org\/10.1080\/09546634.2017.1351608","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"3571_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/srt.12901","volume":"27","author":"M Karrabi","year":"2021","unstructured":"Karrabi M, David J, Sahebkar M (2021) Clinical evaluation of efficacy, safety and tolerability of cysteamine 5% cream in comparison with modified Kligman\u2019s formula in subjects with epidermal melasma: a randomized, double-blind clinical trial study. Skin Res Technol 27(1):24\u201331. https:\/\/doi.org\/10.1111\/srt.12901","journal-title":"Skin Res Technol"},{"issue":"1","key":"3571_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/bjd.13424","volume":"173","author":"P Mansouri","year":"2015","unstructured":"Mansouri P, Farshi S, Hashemi Z, Kasraee B (2015) Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial. Br J Dermatol 173(1):209\u2013217. https:\/\/doi.org\/10.1111\/bjd.13424","journal-title":"Br J Dermatol"},{"issue":"2","key":"3571_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.36849\/JDD.7428","volume":"23","author":"M Sachdev","year":"2024","unstructured":"Sachdev M, Grimes PE, Callender V, Hartman CL, Taylor SC, Elbuluk N et al (2024) Cysteamine Isobionic-amide complex versus kligman\u2019s formula for the treatment of melasma: equal efficacy and rapid onset of action. J Drugs Dermatol 23(2):9\u201316. https:\/\/doi.org\/10.36849\/JDD.7428","journal-title":"J Drugs Dermatol"},{"issue":"7","key":"3571_CR20","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1111\/jocd.15048","volume":"21","author":"M Sepaskhah","year":"2022","unstructured":"Sepaskhah M, Karimi F, Bagheri Z, Kasraee B (2022) Comparison of the efficacy of cysteamine 5% cream and hydroquinone 4%\/ascorbic acid 3% combination cream in the treatment of epidermal melasma. J Cosmet Dermatol 21(7):2871\u20132878. https:\/\/doi.org\/10.1111\/jocd.15048","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"3571_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/s0895-4356(99)00161-4","volume":"53","author":"A Thornton","year":"2000","unstructured":"Thornton A, Lee P (2000) Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol 53(2):207\u2013. https:\/\/doi.org\/10.1016\/s0895-4356(99)00161-4. 16","journal-title":"J Clin Epidemiol"},{"issue":"13","key":"3571_CR22","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1002\/sim.1461","volume":"22","author":"N Terrin","year":"2003","unstructured":"Terrin N, Schmid CH, Lau J, Olkin I (2003) Adjusting for publication bias in the presence of heterogeneity. Stat Med 22(13):2113\u20132126. https:\/\/doi.org\/10.1002\/sim.1461","journal-title":"Stat Med"},{"issue":"8","key":"3571_CR23","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.3390\/antiox10081202","volume":"10","author":"HK Lee","year":"2021","unstructured":"Lee HK, Ha JW, Hwang YJ, Boo YC (2021) Identification of L-Cysteinamide as a potent inhibitor of tyrosinase-mediated dopachrome formation and eumelanin synthesis. Antioxid (Basel) 10(8):1202. https:\/\/doi.org\/10.3390\/antiox10081202","journal-title":"Antioxid (Basel)"},{"issue":"6","key":"3571_CR24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jpha.2020.03.007","volume":"10","author":"C Atallah","year":"2020","unstructured":"Atallah C, Charcosset C, Greige-Gerges H (2020) Challenges for cysteamine stabilization, quantification, and biological effects improvement. J Pharm Anal 10(6):499\u2013516. https:\/\/doi.org\/10.1016\/j.jpha.2020.03.007","journal-title":"J Pharm Anal"},{"issue":"6","key":"3571_CR25","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.bbadis.2011.02.010","volume":"1812","author":"MJ Wilmer","year":"2011","unstructured":"Wilmer MJ, Kluijtmans LA, van der Velden TJ, Willems PH, Scheffer PG, Masereeuw R et al (2011) Cysteamine restores glutathione redox status in cultured cystinotic proximal tubular epithelial cells. Biochim Biophys Acta 1812(6):643\u2013651. https:\/\/doi.org\/10.1016\/j.bbadis.2011.02.010","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"3571_CR26","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.36849\/jdd.6367","volume":"20","author":"S Desai","year":"2021","unstructured":"Desai S, Hartman C, Grimes P, Shah S (2021) Topical stabilized cysteamine as a new treatment for hyperpigmentation disorders: melasma, post-inflammatory hyperpigmentation, and lentigines. J Drugs Dermatol 20(12):1276\u20131279. https:\/\/doi.org\/10.36849\/jdd.6367","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"3571_CR27","first-page":"350","volume":"20","author":"A Sherban","year":"2022","unstructured":"Sherban A, Wang JV, Geronemus RG (2022) Examination of the utility of cysteamine in the treatment of Melasma: current perspectives. Skinmed 20(5):350\u2013352","journal-title":"Skinmed"},{"issue":"12","key":"3571_CR28","doi-asserted-by":"publisher","first-page":"e15961","DOI":"10.1111\/dth.15961","volume":"35","author":"AG Dos Santos-Neto","year":"2022","unstructured":"Dos Santos-Neto AG, da Silva \u00cdCV, Melo CR, Santana AAM, de Albuquerque-Junior RLC (2022) Is cysteamine use effective in the treatment of melasma? A systematic review and meta-analysis. Dermatol Ther 35(12):e15961. https:\/\/doi.org\/10.1111\/dth.15961","journal-title":"Dermatol Ther"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03571-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03571-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03571-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T09:02:31Z","timestamp":1734166951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03571-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,14]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3571"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03571-3","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,14]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a systematic review and meta-analysis study. The Faculty of Medicine, Sam Ratulangi University Research Ethics Committee has confirmed that no ethical approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}}],"article-number":"117"}}